FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Acetaminophen and Codeine Phosphate Oral Suspension USP (Capital and Codeine)
Status: Discontinuation
»Therapeutic Categories:

Valeant Pharmaceuticals North America LLC (New 01/27/2017)

Company Contact Information:
800-321-4576

Presentation Posting Date Related Information
Capital and Codeine (acetaminophen and codeine phosphate oral suspension USP), 16 oz. bottles (NDC 0187-0003-01) 01/27/2017 The company has made a business decision to discontinue manufacturing of the product.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English